Investment Summary

Odido Invests In Simpel

On October 16, 2020, Odido invested in communications company Simpel from Parcom

Investment Highlights
  • This is Odido’s 1st transaction in the Communications sector.
  • This is Odido’s 1st transaction in the Netherlands.

Investment Summary

Date 2020-10-16
Target Simpel
Sector Communications
Investor(s) Odido
Sellers(s) Parcom
Deal Type Stake Purchase

Target

Simpel

Amsterdam, Netherlands
Simpel is a provider of mobile communication services. It offers services as a Mobile Virtual Network Operator (“MVNO”). Simpel was established in 2009 and is based in Amsterdam, Netherlands.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Odido

Den Haag, Netherlands

Category Company
Founded 1999
Sector Communications
DESCRIPTION

Odido is a telecom provider for consumers and businesses With the brands T-Mobile, Tele2, Simpel and Ben, customers have access to interactive TV, mobile and fixed internet and calling. Odido was founded in 1999 and is based in Den Haag, Netherlands.


DEAL STATS #
Overall 1 of 1
Sector: Communications M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: Netherlands M&A 1 of 1
Year: 2020 M&A 1 of 1

Seller(S) 1

SELLER

Parcom

Amsterdam, Netherlands

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1982
PE ASSETS 2.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Parcom Capital is a Dutch middle-market private equity group focused on opportunities in the Netherlands. The Firm targets companies with €50 to €500 million of revenue and €10 to €50 million of EBITDA. Sectors of interest include oil & gas, industrial, distribution, and manufacturing. Parcom Capital operates as a subsidiary of financial services firm ING and is based in Amsterdam.


DEAL STATS #
Overall 20 of 30
Sector: Communications M&A 1 of 1
Type: Stake Purchase M&A Deals 2 of 4
Country: Netherlands M&A 15 of 25
Year: 2020 M&A 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-03 ViroClinics

Rotterdam, Netherlands

ViroClinics is a virology contract research organization, serving the biopharmaceutical community with a broad range of preclinical, clinical diagnostic, assay development and clinical trial logistics services. Operating at a global level, Viroclinics is the preferred virology testing laboratory for several of the top-10 biopharmaceutical companies. Viroclinics’ extensive experience with clinical and preclinical studies for viruses, including its specialty in respiratory viruses, puts the company at the forefront in supporting the development of vaccines, antibodies and antiviral compounds targeting viral infectious diseases. ViroClinics was founded in 2001 and is based in Rotterdam, Netherlands.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-22 Group of Butchers

Tilburg, Netherlands

Group of Butchers is a provider in the development and sale of fresh cold cuts, grilled meat products, and fresh Filet Americain. Its broad range of high-quality meat and sausage products is primarily distributed by leading retail chains in Netherlands, Belgium, and Germany. Group of Butchers was founded in 1997 and is based in Tilburg, Netherlands.

Buy -